- Home
- /
- Thymosin Alpha-1 5mg
Thymosin Alpha-1 5mg
Certificate of Analysis
HPLC + Mass Spectrometry included with order
Thymosin Alpha-1 (Ta1) is a 28-amino acid peptide originally isolated from thymic tissue. It is one of the most extensively studied immunomodulatory peptides, with an approved pharmaceutical version (Zadaxin) used in over 30 countries for specific clinical indications.
Research has investigated Thymosin Alpha-1 across immune system modulation, vaccine adjuvancy, and immunodeficiency. It acts primarily through activation of Toll-like receptors (TLR2, TLR9), dendritic cell maturation, and enhancement of T-cell function. Published studies span viral infections, immune senescence, and oncology-related immunomodulation.
Kyrolab sources Thymosin Alpha-1 from Aurora Bio — the only vertically integrated (self-manufacturing) supplier in our network — ensuring complete supply chain transparency.
Independently Verified Purity: 99.830%
Tested by Janoshik Analytical (Prague) — Task #99128, 3 February 2026.
Actual content: 5.51mg per vial (10% overfilled vs stated 5mg dose).
Batch: TA15J122P | Self-manufactured by Aurora Bio.
Verification: janoshik.com/verify — Key:
JTQD8L5GKZXN
Specifications
| Also Known As | Ta1, Zadaxin (pharmaceutical name) |
| Molecular Weight | 3108.27 g/mol |
| CAS | 62304-98-7 |
| Sequence | 28 amino acid peptide (Ac-SDAAVDTSSEITTKDLKEKKEVVEEAEN) |
| Receptor Targets | TLR2, TLR9 |
| Appearance | White lyophilised powder |
| Storage | 2-8°C, protect from light |
This product is sold strictly for in-vitro research and laboratory purposes. Not for human or animal consumption. Not evaluated by the MHRA or FDA. Must be 18+ to purchase. By purchasing, you agree to our Research Disclaimer and Terms of Service.
| Catalogue Number | KYR-THYMOSINA15MG |
| Compound Name | Thymosin Alpha-1 5mg |